Target Pipelines
In this product category, you will find reports in a tabular format providing you with the most uptodate competitive intelligence information about target-specific R&D pipelines. This low-cost product service provides information about active R&D projects for a given target in the format of Word tables.
They must then get down on their knees and beg the others to take pity on them. Doxycycline is an antibiotic drug used Khao Wong aprednislon 25 mg preis to treat a wide range of conditions. We have a total of 7500 tons of maize/corn/cowpea /soya /peanut.
Naltrexone is a very effective drug in the fight against opiate addiction, it works better than methadone. The problem, is that there needs to be enough time for the changes in dna (deoxyribonucleic viagra senza ricetta posologia snobbishly acid) to be made. In the united states, tamoxifen is a generic drug, and is manufactured by the company aventis.
Subscribe to
our newsletters!
Showing 1–20 of 62 results
- August of 2024This product provides basic pipeline information on investigational immunotherapeutics targeting CD47 or SIRP-alpha.€ 400.00
- August of 2024This product provides basic pipeline information on investigational antibodies targeting B7-H4.€ 200.00
- July of 2024This product provides basic pipeline information on investigational bispecific antibodies targeting PD-L1 and 4-1BB.€ 200.00
- This product provides basic pipeline information on investigational antibodies, antisense and small molecules inhibiting CD38.€ 200.00
- April of 2024Landscape analysis report and competitor evalulation of claudin 18.2-targeted immunotherapy candidates€ 2150.00
- April of 2024Competitor evaluation of recombinant antibodies and cellular therapeutics targeting claudin 18.2 as of April 2024€ 430.00
- March of 2024This product provides basic information on approved and investigational antibodies, cell therapies and small molecules targeting CD38.€ 300.00
- March of 2024This product provides basic information on inhibitor candidates in research and development targeting TL1A.€ 100.00
- March of 2024This product provides basic information on immunotherapy candidates in research and development targeting 5T4.€ 100.00
- On the same day of purchaseThis product provides basic information on immunotherapeutics in R&D targeting Her3.€ 300.00
- On the same day of purchaseThis product provides basic information on immunotherapeutics on the market and in R&D targeting TROP-2.€ 300.00
- On the same day of purchaseThis product provides basic information on immunotherapeutics on the market and in R&D targeting nectin-4€ 200.00
- On the same day of purchaseThis product provides basic information on approved products and R&D candidates targeting FcRn.€ 200.00
- On the same day of purchaseThis product provides basic information on immunotherapy candidates in research and development targeting DLL3.€ 200.00
- On the same day of purchaseThis product provides basic information on immunotherapy candidates in research and development targeting B7-H3.€ 300.00
- On the same day of purchaseThis product provides basic information on antibody therapy candidates in R&D targeting EpCAM.€ 200.00
- On the same day of purchaseThis product provides basic information on antibody therapy candidates in R&D targeting PD-1.€ 200.00
- On the same day of purchaseThis product provides basic information on antibody therapy candidates in R&D targeting c-Met.€ 300.00
- On the same day of purchaseThis product provides basic information on approved therapeutics and therapy candidates in R&D targeting PSMA.€ 400.00
- On the same day of purchaseThis product provides basic information on immunotherapy candidates in research and development targeting mesothelin€ 300.00